 It's a complicated problem. I hope I get that across to everyone that there's no one simple silver bullet here. And with onshoring, too, isn't there the issue of our environmental laws? Because when it comes to making these APIs, the active pharmaceutical ingredients, some of them produce very toxic waste, right? So we probably couldn't.